Testing on primates is currently an important tool for pharmaceutical development. The role of primates in creation and testing of new pharmaceutical products remains significant even in the light of the recent advances related to in vitro, in silico and other alternative laboratory testing models.
National BioService has the joint venture (NBS-South) with the biggest in Russia NHP research facility – The Research Institute of Medical Primatology and provides a wide range of research services involving non-human primates. The Institute keeps about 5,200 animals.
The NHP collection includes
- Rhesus macaque (Macaca mulatta)
- Cynomolgous macaque (Macaca fascicularis)
- Hamadryas baboon (Papio hamadryas)
- Anubis baboon (Papio anubis)
- Green monkey (Chloro cebusaethiops)
Biospecimens available
- Biological fluids: whole blood, serum, plasma, and other biological fluids upon request
- Tissues: fresh, frozen, FFPE, tissue microarrays (TMAs)
- Cells: PMMCs, BBMCs, buffy coat layer, and other types of cells
PRECINICAL STUDIES OPPORTUNITY
- Therapeutic and diagnostic antibodies studies on FDA and customized tissue micro arrays (TMA)
- Immunogenicity testing: the best methods to assess the total anti-drug antibodies (ADAs)
- PK studies and PK sample analysis
- Custom protocols and regular toxicological studies in NHP
Cites approved worldwide shipping
Animal welfare compliance